Strides Shasun has received final USFDA approval for cetirizine hydrochloride capsules, used to relieve allergy symptoms. The drug cetirizine hydrochloride will be made available in […]
Lupin Ltd has received final USFDA approval to market a generic version of County Line Pharmaceuticals, LLC’s Fluocinonide Topical Solution. The solution is used to […]
Alembic Pharmaceuticals has received the final USFDA approval for Abbreviated New Drug Application (ANDA) of anti-bacterial Doxycycline capsules USP 75 mg and 100 mg. The […]
Strides Shasun today has received final USFDA approval for memantine hydrochloride tablets used in the treatment of dementia. The product will be manufactured at the […]
Glenmark Pharmaceuticals has received final USFDA approval for generic version of Strattera capsules, used in the treatment of attention-deficit/hyperactivity disorder (ADHD). The company has been […]
Zydus Cadila has received final USFDA approval to market Felbamate tablets, used to treat seizures in people with epilepsy, in the American market. The company […]
Zydus Cadila has received final USFDA approval to market antihistamine Cyproheptadine Hydrochloride tablets in the US market. The tablets are used to relieve allergy symptoms […]
Zydus Cadila has received final USFDA approval to market levofloxacin injection, used to treat bacterial infections, in the American market. The drug injection is made […]
Zydus Cadila has received USFDA approval to market Mirtazapine orally disintegrating tablets, an anti depressant, in the US market. The drug will be marketed in […]
Zydus Cadila has received approval from USFDA to market mesalamine tablets used for the treatment of ulcerative colitis. The US FDA has given its final […]
Copyright © 2024 | WordPress Theme by MH Themes